Drug eluting stents: are human and animal studies comparable?
about
Axial stent strut angle influences wall shear stress after stent implantation: analysis using 3D computational fluid dynamics models of stent foreshortening.The representative porcine model for human cardiovascular diseaseNeointimal hyperplasia persists at six months after sirolimus-eluting stent implantation in diabetic porcineEffects of an alpha-4 integrin inhibitor on restenosis in a new porcine model combining endothelial denudation and stent placementDrug-eluting stents in preclinical studies: updated consensus recommendations for preclinical evaluation.A selective microRNA-based strategy inhibits restenosis while preserving endothelial function.Intravascular fibrin molecular imaging improves the detection of unhealed stents assessed by optical coherence tomography in vivo.Alterations in regional vascular geometry produced by theoretical stent implantation influence distributions of wall shear stress: analysis of a curved coronary artery using 3D computational fluid dynamics modeling.Comparison of bare metal stent and paclitaxel-eluting stent using a novel rat aorta stent modelDrug-eluting stents: new era and new concerns.Early experiences and clinical implications of drug-eluting stents: part 1.In stent restenosis: bane of the stent era.Differential healing after sirolimus, paclitaxel, and bare metal stent placement in combination with peroxisome proliferator-activator receptor gamma agonists: requirement for mTOR/Akt2 in PPARgamma activationThe future of drug eluting stents.Drug-eluting stents: from evidence to policy.BioMatrix Biolimus A9-eluting coronary stent: a next-generation drug-eluting stent for coronary artery disease.Pathology of atherosclerosis and stentingEffects of Methotrexate in a Rabbit Model of In-Stent Neoatherosclerosis: An Optical Coherence Tomography Study.Frequency of Vascular Inflammation and Impact on Neointimal Proliferation of Drug Eluting Stents in Porcine Coronary Arteries.Drug-eluting stent safety: findings from preclinical studies.Long-term effect of stents eluting 6-mercaptopurine in porcine coronary arteries.A novel polymer-free ciglitazone-coated vascular stent: in vivo and ex vivo analysis of stent endothelialization in a rabbit iliac artery model.Preclinical models of restenosis and their application in the evaluation of drug-eluting stent systems.Factors that affect mass transport from drug eluting stents into the artery wall.Drug-coated balloon therapy in coronary and peripheral artery disease.Current application and bioavailability of drug-eluting stents.Healing arterial ulcers: Endothelial lining regeneration upon vascular denudation injury.Application of an enhanced device to transluminal retrieval of malappositioned coronary stents: An experimental study.Miniature Swine for Preclinical Modeling of Complexities of Human Disease for Translational Scientific Discovery and Accelerated Development of Therapies and Medical Devices.Analysis of neointima development in flow diverters using optical coherence tomography imaging.Paving the way to a bioresorbable technology: Development of the absorb BRS program.Evaluation with in vivo optical coherence tomography and histology of the vascular effects of the everolimus-eluting bioresorbable vascular scaffold at two years following implantation in a healthy porcine coronary artery model: implications of piloQuantitative precision of optical frequency domain imaging: direct comparison with frequency domain optical coherence tomography and intravascular ultrasoundEffect of cilostazol on neointimal hyperplasia in iliac arteries of pigs after transluminal angioplasty.Comparison of early vascular morphological changes between bioresorbable poly-L-lactic acid scaffolds and metallic stents in porcine iliac arteries.Sirolimus and paclitaxel provoke different vascular pathological responses after local delivery in a murine model for restenosis on underlying atherosclerotic arteries.Serial changes of neointimal tissue after everolimus-eluting stent implantation in porcine coronary artery: an optical coherence tomography analysis.Predicting in vivo efficacy of potential restenosis therapies by cell culture studies: species-dependent susceptibility of vascular smooth muscle cells.Two-week interval optical coherence tomography: imaging evidence on neointimal coverage completion after implantation of the Endeavor zotarolimus-eluting stent.Stent-based tempamine delivery on neointimal formation in a porcine coronary model.
P2860
Q24813145-ECF30EA0-E1DF-44DA-81A0-332263CBF9C6Q27692622-95E9CF73-A491-48F8-A15A-C94FFE421C47Q28212482-A2514461-F542-43F6-870E-5ED9194C0726Q28476506-20F54440-5999-47BD-844E-1821C3412181Q34109253-F0D0E7FE-8C8F-40AC-B57F-14C50F7724FBQ34129012-A377E6E2-30B8-4054-8076-DD9160D80D7DQ34505823-8C27CDB0-2A64-4628-ABC9-83BE5B99BA2EQ34997709-24CC359C-DCA8-442F-9A58-B1E3C848F6ADQ35013930-121A6E79-9A45-4652-92D1-F6E2522DC857Q35647727-8AE99AC4-A069-4CB0-B719-D67C87F79A5AQ35651217-6CCD2990-DCFD-48F7-AAEF-D267032CB459Q35769824-CCEC8EED-0A64-48E4-BCED-4A44C6BAACF0Q35820068-AE27E795-BBE1-45B7-AAB8-B817267B1F55Q36282715-E8FE42AB-2FCE-4A08-B37D-27180E3F1B71Q36314909-FF974803-199B-44B2-90D0-918A9CF6BC1DQ36728852-D66173A0-49AB-4F3D-8FDC-CCEC8007E2C3Q36934746-DBB43A44-B79A-41AA-A51D-594A97007BE4Q37267458-C013A692-1FAB-45EE-9850-0D2139412B0BQ37314517-E12B4C2D-7965-43D2-B84B-D2A60E105B04Q37329149-16EE31C7-6CAD-47DC-9C6B-6CC596D7D151Q37472459-E99DF7A2-DF58-4E94-9692-6CE5E9056A09Q37628900-29A59CFF-851A-40AB-B60C-F98704916414Q37676695-25A32F22-0803-4EBC-822D-5A33115C2A73Q37705587-7A4BB043-89F0-4944-AC1C-2E1591A857FFQ38159879-96510EE9-2385-4C75-80E6-DFC8352E5312Q38188578-9EB11CBA-6B8B-4589-884D-42B554CC2ABAQ38532954-85B73D1E-BF23-40E2-A5DC-FF68AA2C0F9AQ38612090-F79968B5-E176-4136-8432-B1A7AC73830EQ38721240-E169CAB2-1A8B-42B8-B149-FD5D9F0FCBDAQ38737629-7DF85FC6-9067-46D8-90F3-2FD3E44FE272Q38995000-135B4730-80F4-4F5C-B802-CC52C5B73187Q39759317-8EAAE04B-3E6F-4E7A-8B73-9FABB316C475Q40001938-34474AC0-ED7F-4324-A557-68054533A3FBQ40306833-F5B862F3-0352-4C22-B914-99B280C9F63AQ40436446-99B0A52E-FF24-4617-AD1D-CAF0F873CD71Q41390902-1FBC44E8-A595-45C8-AB26-9970335223D4Q41981596-D75EE184-6FA5-4CDC-A3EC-CF198B750FBAQ43250028-AB52ED85-3E15-4F4B-825D-ED6C234566BEQ43904464-E4A6C42A-D92B-420C-8FFF-E06D1C8765A1Q44926557-CC24B9AC-C400-431C-A7A7-4010B5344C87
P2860
Drug eluting stents: are human and animal studies comparable?
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Drug eluting stents: are human and animal studies comparable?
@en
type
label
Drug eluting stents: are human and animal studies comparable?
@en
prefLabel
Drug eluting stents: are human and animal studies comparable?
@en
P2093
P2860
P356
P1433
P1476
Drug eluting stents: are human and animal studies comparable?
@en
P2093
P2860
P304
P356
10.1136/HEART.89.2.133
P407
P577
2003-02-01T00:00:00Z